KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cme (CME) Gross Margin (2016 - 2025)

Cme (CME) has disclosed Gross Margin for 17 consecutive years, with 94.79% as the latest value for Q4 2025.

  • On a quarterly basis, Gross Margin rose 72.0% to 94.79% in Q4 2025 year-over-year; TTM through Dec 2025 was 96.19%, a 55.0% increase, with the full-year FY2025 number at 96.19%, up 55.0% from a year prior.
  • Gross Margin was 94.79% for Q4 2025 at Cme, down from 96.42% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 96.86% in Q2 2025 to a low of 92.13% in Q4 2022.
  • A 5-year average of 95.38% and a median of 95.8% in 2023 define the central range for Gross Margin.
  • Peak YoY movement for Gross Margin: surged 177bps in 2021, then crashed -81bps in 2022.
  • Cme's Gross Margin stood at 92.95% in 2021, then dropped by -1bps to 92.13% in 2022, then rose by 1bps to 92.92% in 2023, then increased by 1bps to 94.07% in 2024, then increased by 1bps to 94.79% in 2025.
  • Per Business Quant, the three most recent readings for CME's Gross Margin are 94.79% (Q4 2025), 96.42% (Q3 2025), and 96.86% (Q2 2025).